Clin2
NCT06679426Possibly a fitNot yet recruiting

Study of a drug for swelling caused by blood pressure medication

ACE Inhibitor-Induced Angioedema

Part of Heart & circulation, Immune system & allergy, Skin clinical trials.

This trial tests a medicine called conestat alfa in people who get swelling in the head or neck from their blood pressure medication (ACE inhibitors). The goal is to see if the drug can treat this swelling and help patients avoid serious breathing problems.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
24 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You take a blood pressure medicine called an ACE inhibitor and have swelling in your head or neck because of it.
  • Your swelling is at least moderate and started within the last 24 hours.
  • You have at least one symptom like trouble breathing, trouble swallowing, voice changes, or tongue swelling.
  • You are not allergic to rabbits or medicines made from rabbit products.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06210698Recruiting
Angioedema biomarker research study

This study collects blood samples (and optional skin samples) from people with angioedema to learn more about the condition and find better ways to diagnose and treat it. If you join, you may help scientists understand angioedema better.

Wheaton, Maryland
NCT04763577Recruiting
Testing enzymes in ACE-inhibitor–related facial swelling

This trial studies what happens in the body’s enzyme system in people who get facial swelling (angioedema) from certain blood pressure medicines called ACE inhibitors. The goal is to better understand the cause and potentially guide safer treatment for future episodes.

Grenoble
NCT06361537Recruiting· Phase 3
Study of a C1 inhibitor medicine for HAE attacks

This trial tests a plasma-derived C1 esterase inhibitor to treat and prevent acute attacks in people with hereditary angioedema (HAE) types 1 or 2. It aims to see if the medicine can quickly relieve swelling episodes and reduce their frequency.

Centennial, Colorado
NCT07654829Not yet recruiting· Phase 4
Sebetralstat to prevent swelling before procedures in HAE

This trial tests if sebetralstat can prevent swelling attacks before medical procedures in people with HAE types I or II. You take the medicine short-term before your procedure to see if it helps protect you from an attack.

Colorado Springs, Colorado
NCT07293364Recruiting
Study of C1-inhibitor test for hereditary angioedema diagnosis

This study checks if a blood test measuring C1-inhibitor function can help diagnose hereditary angioedema (HAE), a rare condition that causes painful swelling episodes. If you or a close family member have had swelling without rash or itching that lasts 1-5 days and doesn't get better with allergy meds, this trial may be for you.

Algiers
NCT06960213Recruiting· Phase 3
Study of ADX-324 for preventing HAE attacks

This study tests a new medicine called ADX-324 to see if it can prevent HAE attacks in adults with type I or II HAE. If you've had attacks recently and are willing to pause your current prevention medication, this trial may be an option.

Litchfield Park, Arizona

Hear when a new ACE Inhibitor-Induced Angioedema trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.